)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
IM Cannabis
IM Cannabis (IMCC) investor relations material
IM Cannabis Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary5 Feb, 2026
Company overview and business model
Operates internationally, focusing on medical cannabis markets in Israel and Germany, leveraging a data-driven supply chain and regulatory expertise.
Shifted strategic focus to Germany after partial legalization in 2024, aiming for significant growth in the expanding medical cannabis sector.
In Israel, operates licensed pharmacies, online retail, and home delivery, enhancing direct patient access and brand recognition.
German operations include a logistics center and EU-GMP production facility, repackaging, and third-party services.
Financial performance and metrics
As of February 2026, received US$2,132,912 in gross proceeds from promissory notes and warrants.
Capitalization as of September 30, 2025: pro forma as adjusted total equity of C$8,043,000 and total capitalization of C$23,654,000.
Recent private placements in 2025 and 2026 raised additional capital through convertible notes and warrants.
Use of proceeds and capital allocation
Net proceeds from promissory notes allocated to debt repayment and general corporate purposes.
Proceeds from warrant exercises, if any, intended for working capital, debt repayment, and general corporate purposes.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from IM Cannabis
- Q4 revenue up 25% and Germany sales soared 183%, driving positive adjusted EBITDA.IMCC
Q4 202417 Mar 2026 - German sales surged 129% post-legalization, but margin pressure led to a CAD 3.5M net loss.IMCCQ2 20241 Feb 2026
- Revenue up 12% and adjusted EBITDA loss down 82%, driven by German growth and efficiency.IMCCQ3 202413 Jan 2026
- Seeking up to $50M for expansion, with focus on Germany and ongoing risks in Israel.IMCCRegistration Filing16 Dec 2025
- Resale of nearly 5M shares enables capital for growth in Germany and Israel, with Nasdaq listing.IMCCRegistration Filing16 Dec 2025
- Refocused on Germany’s medical cannabis market, with growth funded by recent private placements.IMCCRegistration Filing16 Dec 2025
- Profitability and margin growth in Q1 2025, led by German gains and cost reductions.IMCCQ1 202519 Nov 2025
- Stable revenue but higher net loss in Q3 2025 due to impairment and margin decline.IMCCQ3 202513 Nov 2025
- Profitability and margins improved sharply in Q2 2025 despite a 14% revenue drop.IMCCQ2 202512 Aug 2025
Next IM Cannabis earnings date
Q4 20253 Apr, 2026
IM Cannabis
Next IM Cannabis earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage